Cite

HARVARD Citation

    Rückert, T. et al. (n.d.). S230: HUMAN ΒETA-DEFENSIN 2 TREATMENT MODULATES THE INTESTINAL MICROBIOME AND THE ALLOGENEIC T CELL RESPONSE TO LIMIT ACUTE GRAFT-VERSUS-HOST DISEASE. HemaSphere. pp. 131-132. [Online]. 
  
Back to record